Clinical Trials
AVEO Releases Phase 2 Data
May 3, 2012 11:29 am | News | CommentsA Phase 2 study has compared a combination of ficlatuzumab and gefitinib to gefitinib monotherapy in previously untreated Asian subjects with non-small cell lung cancer.
Gilead Begins GS-1101 Trial
May 3, 2012 11:16 am | News | CommentsGilead Sciences Inc. announced that the first patient has been dosed in a Phase 3 clinical trial evaluating the efficacy and safety of GS-1101.
Quotient Receives Enterion Approval
May 2, 2012 11:42 am | News | CommentsQuotient Clinical has received approval of the final patent for its Enterion technology. This completes a portfolio of eight granted patents across North America and Europe.
Vyvanse Evaluated for Binge Eating
May 1, 2012 10:53 am | News | CommentsShire plc announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse in adults with binge eating disorder.
Quark to Begin Phase 2a Study
May 1, 2012 10:47 am | News | CommentsQuark Pharmaceuticals Inc. it has amended an existing exclusive licensing agreement with Pfizer in order to perform a Phase 2a clinical trial of PF-655 on patients with open-angle glaucoma.
Idenix Reports HCV Data
May 1, 2012 10:27 am | News | CommentsA JMP Securities analyst has upgraded Idenix Pharmaceuticals Inc. stock after Idenix reported new data on its experimental hepatitis C drugs.
FDA Approves Impotence Drug
April 30, 2012 11:11 am | News | CommentsThe Food and Drug Administration approved a new impotence drug, Vivus Inc.'s Stendra. Vivus is talking to potential marketing partners, or it may sell the drug to another company.
Repligen Releases RG3039 Data
April 27, 2012 11:30 am | News | CommentsRepligen Corporation announced positive results from a Phase 1 study of RG3039, a drug candidate for the potential treatment of spinal muscular atrophy.
FDA Approves Votrient
April 27, 2012 11:14 am | News | CommentsGlaxoSmithKline plc announced that the U.S. Food and Drug Administration has approved Votrient for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy.
Alemtuzumab Outperforms Rebif in New Trial
April 26, 2012 10:48 am | News | CommentsGenzyme has reported data from a Phase 3 trial that showed accumulation of disability was significantly slower in multiple sclerosis patients who were treated with alemtuzumab versus Rebif.
Potential DMD Treatment Moves to Clinic
April 25, 2012 11:07 am | News | CommentsSMT C1100, an experimental treatment for Duchenne muscular dystrophy, has received approval from regulatory agencies in the United Kingdom to move from laboratory to human testing.
Second MDT-637 Trial Wraps Up
April 25, 2012 11:01 am | News | CommentsMicroDose Therapeutx, Inc. has concluded the second of two Phase 1 studies with its inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RSV infection.
IU Pouring $150M into Research Collaboration
April 25, 2012 10:33 am | News | CommentsIndiana University Health and the Indiana University School of Medicine will invest $150 million in a new research collaboration that will enhance the institutions’ capabilities in fundamental scientific investigation, translational research, and clinical trials.
Zerenex Succeeds in Japan Study
April 24, 2012 10:31 am | News | CommentsKeryx Biopharmaceuticals said its kidney disease drug Zerenex, a treatment for high phosphate levels in dialysis patients, met its goal in a late-stage clinical trial.
Asthma Sufferers Benefit from SNG001 Treatment
April 23, 2012 11:03 am | News | CommentsSynairgen plc has announced positive data from its Phase 2 clinical trial to assess SNG001's ability to protect asthmatics from respiratory virus infections that can spread to the lung.
Abbott Releases Phase 2 Results
April 20, 2012 11:08 am | News | CommentsAbbott announced data from an interferon-free, Phase 2 study of Abbott's direct-acting antiviral medicines for hepatitis C that showed over 90% of patients new to HCV treatment achieved SVR12.
Stemline Releases SL-701 Trial Data
April 20, 2012 11:00 am | News | CommentsStemline Therapeutics Inc. has announced study results of two clinical trials of direct injection synthetic peptide vaccine, now being developed as SL-701, in both adults and children with advanced brain cancer.
Gilead, BMS Drug Combo Ace Trial
April 20, 2012 10:26 am | News | CommentsTwo drugmakers said that a combination of experimental oral treatments for hepatitis C cured almost all patients in a midstage clinical trial.
FDA Halts Novartis Trial
April 20, 2012 10:20 am | News | CommentsSwiss pharmaceutical company Novartis AG says it has halted clinical trials for alisporivir, a new drug to treat hepatitis, after one patient died.
Depomed Meets with FDA Over Serada
April 19, 2012 10:52 am | News | CommentsDepomed, Inc. announced that it has completed a Type B pre-NDA meeting with the United States Food and Drug Administration regarding the results of three Phase 3 clinical trials of Serada.
Abbott Releases LCIG Results
April 19, 2012 10:49 am | News | CommentsAbbott announced the results from a Phase 3 trial evaluating the company's investigational compound for advanced Parkinson's disease, levodopa-carbidopa intestinal gel.
Does Food Have an Impact on Cancer Meds?
April 18, 2012 11:22 am | News | CommentsAn unusual clinical trial is seeking to determine whether a drug approved for patients with advanced prostate cancer might be safer and just as effective if taken at a much lower dose with food instead of at the full dose on an empty stomach.
FDA Approves New PLX-PAD Trial
April 18, 2012 11:05 am | News | CommentsThe United States Food and Drug Administration has granted Pluristem Therapeutics Inc. clearance to start a Phase 2 clinical trial using the PLX-PAD cell product candidate for the treatment of intermittent claudication.
MOD-6030 Study Shows Weight Loss
April 18, 2012 10:51 am | News | CommentsPROLOR Biotech Inc. reported positive preclinical results from an animal study of its long-acting obesity/type 2 diabetes drug candidate MOD-6030.
Back Pain Remedy Falls Short
April 17, 2012 11:13 am | News | CommentsDespite hopes that injecting etanercept into the spine could relieve the severe leg and lower back pain of sciatica, a study has found that steroid injections still work better.
